End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.3 MXN | +3.16% | +8.23% | +15.11% |
Business Summary
Number of employees: 1,783
Sales per Business
MXN in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products and Personal Care Products
100.0
%
| 15,487 | 100.0 % | 16,820 | 100.0 % | +8.61% |
Sales per region
MXN in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
International
59.9
%
| 9,024 | 58.3 % | 10,069 | 59.9 % | +11.59% |
Mexico
40.1
%
| 6,464 | 41.7 % | 6,751 | 40.1 % | +4.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | - |
Founder | - | 30/96/30 | |
Director of Finance/CFO | - | - | |
Director/Board Member | - | 10/18/10 | |
Director/Board Member | - | 29/12/29 | |
Public Communications Contact | - | 01/08/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Burkhard Wittek
BRD | Director/Board Member | 70 | 18/18/18 |
Director/Board Member | - | - | |
Founder | - | 30/96/30 | |
Director/Board Member | - | 01/98/01 | |
Director/Board Member | 80 | - | |
Director/Board Member | - | 29/12/29 | |
Director/Board Member | - | 10/18/10 | |
Director/Board Member | - | 18/18/18 | |
Director/Board Member | - | - | |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,020,000,000 | 712,097,600 ( 69.81 %) | 74,855,920 ( 7.339 %) | 69.81 % |
Company contact information
Genomma Lab Internacional SAB de CV
Avendia Antonio Dovalí Jaime, 70 Torre C, Piso 2, Despacho A
01210, Mexico City
+
http://www.genommalab.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.11% | 882M | |
+25.72% | 661B | |
+26.74% | 566B | |
-6.56% | 352B | |
+20.42% | 332B | |
+3.01% | 283B | |
+13.43% | 231B | |
+4.70% | 200B | |
-9.41% | 195B | |
-5.10% | 145B |
- Stock Market
- Equities
- LAB B Stock
- Company Genomma Lab Internacional, S.A.B. de C.V.